Relationship of HbA1c with body weight change over 4 years from starting insulin therapy in people with type 2 diabetes: the CREDIT study

被引：0
|
作者：
Balkau, B. [1 ]
Freemantle, N. [2 ]
Calvi-Gries, F. [3 ]
Pilorget, V. [4 ]
Vincent, M. [4 ]
Home, P. [5 ]
机构：
[1] Univ Paris 11, INSERM, U1018, UMRS 1018, Villejuif, France
[2] UCL, London WC1E 6BT, England
[3] AtlanStat, Reze, France
[4] Sanofi, Paris, France
[5] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
110
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Association of hypoglycaemia with insulin titration and body weight in people with type 2 diabetes commencing insulin glargine 100 U/ml and achieving different HbA1c levels
    Frier, B. M.
    Landgraf, W.
    Zhang, M.
    Bolli, G. B.
    Owens, D. R.
    Home, P. D.
    DIABETOLOGIA, 2017, 60 : S335 - S336
  • [32] Dapagliflozin as Part of Triple Combination Therapy Helps Reduce HbA1c and Body Weight in Patients With Type 2 Diabetes
    Jabbour, Serge
    Hardy, Elise
    Debruin, Tjerk W.
    Gause-Nilsson, Ingrid
    Rohwedder, Katja
    Martin, Paula
    Parikh, Shamik J.
    DIABETES, 2013, 62 : A306 - A307
  • [33] Inverse relationship between HbA1c and serum bilirubin in people with Type 1 diabetes
    Chee, C.
    Gazis, A.
    Mansell, P. M.
    DIABETIC MEDICINE, 2014, 31 : 43 - 43
  • [34] Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
    Monnier, L
    Colette, C
    Thuan, JF
    Lapinski, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) : 231 - 235
  • [35] Survival as a function of HbA1c in people with type 2 diabetes Reply
    Currie, Craig J.
    Poole, Chris D.
    LANCET, 2010, 375 (9724): : 1434 - 1435
  • [36] Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
    Currie, Craig J.
    Peters, John R.
    Tynan, Aodan
    Evans, Marc
    Heine, Robert J.
    Bracco, Oswaldo L.
    Zagar, Tony
    Poole, Chris D.
    LANCET, 2010, 375 (9713): : 481 - 489
  • [37] Trajectories of HbA1c after initiation of insulin therapy in type 2 diabetes mellitus patients
    Mast, R.
    Walraven, I.
    Hoekstra, T.
    Jansen, D.
    van der Heijden, A. A. W.
    Elders, P. J. M.
    Heine, R. J.
    Dekker, J. M.
    Hugtenburg, J. G.
    Nijpels, G.
    DIABETOLOGIA, 2014, 57 : S385 - S385
  • [38] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1512 - 1522
  • [39] Insulin regimens and glycemic control in different parts of Europe over 4 years after starting insulin in people with type 2 diabetes: Data from the CREDIT non-interventional study
    Blonde, Lawrence
    Marre, Michel
    Vincent, Maya
    Brette, Sandrine
    Pilorget, Valerie
    Danchin, Nicholas
    Vespasiani, Giacomo
    Home, Philip
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 150 - 158
  • [40] Lower weight gain and better outcomes in patients with type 2 diabetes starting insulin treatment when baseline HbA1c <8.0%
    Leahy, J.
    Vlajnic, A.
    Rimler, M.
    DIABETOLOGIA, 2011, 54 : S273 - S273
12345